ArticleNature communications2026
Low-burden AI approach for cross-national early identification of cognitive impairment using real-world questionnaire response behaviours.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Low-burden AI approach for cross-national early identification of cognitive impairment using real-world questionnaire response behaviours.Nature communications · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Under-recognition of cognitive impairment remains a major global public health challenge, particularly in low- and middle-income countries. Many cases go unrecognised because conventional cognitive assessment is resource-intensive and difficult to scale across diverse populations. Here we show that easily captured indicators of reduced survey response quality, derived from how older adults answer routine psychosocial questionnaires, can identify cognitive impairment risk across countries. Using data from 45,604 older adults across five population-based ageing cohorts, we develop a cross-nationally generalisable machine-learning pipeline based on a tabular foundation model. Especially, the model jointly trained across the United States, England, India and Mexico outperforms country-specific models, achieving up to a 0.12 absolute gain in the area under the receiver operating characteristic curve (approximately 20% relative) in an external validation cohort from China. We also identify a cross-national implicit feature transfer phenomenon, in which cohorts lacking certain predictors benefit from joint training with cohorts in which these predictors are present. Decision-curve analyses indicate consistent potential public health benefit across countries by supporting population-level prioritisation of higher-risk subgroups. This low-burden approach offers an equitable and scalable strategy for generating population- and community-level evidence on cognitive impairment risk in culturally diverse and resource-constrained settings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.